semaglutide decrease inflammation Is Anti-inflammatory? glp 1 reduces inflammation GLP-1

Many users report stronger appetite reduction within the first two weeks compared to semaglutide

NC Medicaid removed obesity GLP-1 coverage effective October 1, 2025 the CV indication (for members with established CVD), MASH (moderate-to-advanced fibrosis), and OSA indications remain covered under NC Medicaid where the qualifying diagnosis is documented

Cirincione B, Mager DE

Follow-up was representative of real-world practice

What the Clinical Data Actually Shows The most definitive comparison comes from the SURMOUNT-5 trial, a direct head-to-head study published in the New England Journal of Medicine comparing tirzepatide 10 mg and 15 mg against semaglutide 2.4 mg in adults with obesity but without diabetes